Webcast: China - How pharma can maximise success in this rapidly changing emerging market

Marc Yates & An-hwa Lee - November 2020

Complete the form below to view the webcast.

China has always been believed to be the land of promise for multinational pharmaceutical companies. The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, for the pharmaceutical industry. 

China - How pharma can maximise success in this rapidly changing emerging market
China - How pharma can maximise success in this rapidly changing emerging market

Complete the form below to view the webcast.

China has always been believed to be the land of promise for multinational pharmaceutical companies. The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, for the pharmaceutical industry. 

The recent digital transformation as a result of the COVID-19 pandemic has also led China to adopt new approaches to healthcare. Market researchers need to keep up to speed with the changes in order to win in this rapidly changing market. This webcast is presented by emerging market experts Marc Yates and An-hwa Lee

Topics covered in this webinar include:

  • What's planned? An overview of the healthcare environment in China including an assessment of what recent developments mean to you
  • What's changed? The key opportunities, including digital transformations and healthcare reforms 
  • Where to play & how to win: Case studies showcasing how to design an effective marketing strategy, with Oncology and Vaccine examples amongst others

Watch the webcast

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here